Guideline: Treatment of pathological scars (hypertrophic scars and keloids);Therapie pathologischer narben (hypertrophe narben und keloide)

JDDG - Journal of the German Society of Dermatology

Volumn 2, Issue 4, 2004, Pages 308-312

  Koller, J ^a   Sebastian, G ^b  

^a Salzburger Landeskliniken   (Austria)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA TOCOPHEROL; BLEOMYCIN; CALCIUM ANTAGONIST; COLCHICINE; CORTICOSTEROID; FLUOROURACIL; GAMMA INTERFERON; LIDOCAINE; PENTOXIFYLLINE; RECOMBINANT ALPHA2B INTERFERON; SILICONE GEL; TRIAMCINOLONE ACETONIDE; ZINC;

CORTICOSTEROID THERAPY; CRYOSURGERY; KELOID; LASER SURGERY; NOMENCLATURE; PLASTIC SURGERY; PRACTICE GUIDELINE; PROPHYLAXIS; SCAR; SHORT SURVEY;

EID: 1942521007     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0353.2004.03053.x     Document Type: Short Survey

References (31)

1. Pollack S, et al. The Surgical Treatment of Keloids. J Dermatol Oncol 8: 12 1982.
2. Tredget E, et al. Hypertrophic Scars, Keloids, and Contractures. Surgical Clinics of North America, Vol 77 No 3, June 1997.
3. Schäffer M, et al. Nitric Oxide, an Autocrine Regulator of Wound Fibroblast Synthetic Function. The Journal of Immunology, 1997, 158: 2375-2381.
4. Tang YW. Intra- and postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg 1992; 45: 371-373.
5. Espinassouze F et al. Traitement De Chéloïdes Par Injections Intra-Lésionnelles D'Interféron Alpha-2B. Ann Dermatol Venereol 1993; 120: 629-630.
6. Panizzon R. G. Radiation Therapy of Benign Tumors, Hyperplasias, and Dermatoses.: Goldschmidt H. and Panzizzon R. G. (Editors): Modern Dermatologic Radiation Therapy, Springer, New York, Berlin, Heidelberg etc., 1991, 139-146.
7. Niessen F, et al. The role of Suture Material in Hypertrophic Scar Formation: Monocryl vs. Vicryl-rapide.
8. Niessen F, et al. The Use of Silicone Occlusive Sheeting (Sil-K) and Silicone Occlusive Gel (Epiderm) in the Prevention of Hypertrophic Scar Formation. Plast Reconstr Surg Vol Nov 1998; 102: 1962-72.
9. Berman B, et al. Recurrence rates of excided keloids treated with postoperative triamcinolone acetone injections or interferon alfa-2b injections. J Am Acad Dermatol 1997; 37: 755-7.
10. Pittet B, et al. Effect of γ-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast Reconstr Surg 1994; 93: 1224-35.
11. Berman B et al. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminglycan, and collagenase production in vitro. J Am Acad Dermatol 1989; 21: 684-702.
12. Tredget E et al. Transforming Growth Factor-β in Thermally Injured Patients with Hypertrophic Scars: Effects of Interferon α-2b. Plast Reconstr Surg 1989;1329-30.
13. Klumpar D et al. Keloids treated with excision followed by radiation therapy. J Am Acad Dermatol 1994; 31: 225-31.
14. Baum TM, et al. Use of a glycerin-based gel sheeting in scar management. Adv Wound Care 1998 Jan-Feb; 11(1): 40-3.
15. Clugston P et al. Evaluation of Silicone-Gel Sheeting on Early Wound Healing of Linear Incisions. Ann Plast Surg 1995; 34: 12-15.
16. Zitelli J et al. Buried Vertical Mattress Suture. J Dermatol Oncol 1989; 15: 17-19.
17. Engrav I et al. A Comparison of Intra-marginal and Extramarginal Excision of Hypertrophic Burn Scars. Plast Reconstr January 1988; 81: 40-43.
18. Suzuki S, Versatility of modified planimetric Z-plasties in the treatment of scar with contracture. Br J Plast Surg 1998 Jul; 51(5): 363-9.
19. Haas A et al. Cultured Epithelial Autografts in the Treatment of Extensive Recalcitrant Keloids. Arch Dermatol May 1998; 134: 549-552.
20. English R et al. Keloids and Hypertrophic Scars. Dermatol Surg 1999; 25: 631-638.
21. Goldman M, Fitzpatrick R. Laser Treatment of Scars. Dermatol Surg 1995; 21: 685-687.
22. Granstein RD et al. A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Clinical and histologic findings. Arch Dermatol 1990 Oct; 126(10): 1295-302.
23. Broker BJ et al. Keloid excision and recurrence prophylaxis via intradermal interferon-gamma injections: a pilot study. Laryngoscope 1996 Dec; 106 (12 Pt 1): 1497-501.
24. Ernst K, Hundeiker M. Ergebnisse der Kryochirurgie bei 394 Patienten mit hypertrophen Narben und Keloiden. Hautarzt (1995) 46: 462-466.
25. Paquet P, Hermans JF, Pierard GE. Effect of the 585 nm flashlamp-pumped pulsed dye laser for the treatment of keloids. Dermatol Surg 2001 Feb; 27(2): 171-4.
26. Janicki St. Effect of ointments for treatment scars and keloids on metabolism of collagen in scar and healthy skin. Eur.J Pharm.Biopharm, 1991, Vol. 37(3), p. 188-191.
27. Younai S et al. Modulation of Collagen Synthesis by Transforming Growth Factor-β in Keloid and Hypertrophic Scar Fibroblasts. Annals of Plastic Surgery 1994, Vol. 33 (2), p. 148-151.
28. Schäffer M et al. Stickstoffmonoxid: Mediator der Gewebsreparation. Dtsch. med. Wschr. 122 (1997), 339-345.
29. Apfelberg DB et al. The use of epidermis over a keloid as an autograft after resection of the keloid. J. Dermatol. Surg. 2: 409-411, 1976.
30. Cosman B et al. Correlation of keloid recurrence with completeness of local excision. Plast. Reconstr. Surg. 50: 163-166, 1972.
31. Sebastian G et al. Möglichkeiten zur Objektivierung der Effizienz der Kryotherapie bei Keloiden. In: Koller J, Hutner H (Hrsg) Fortschritte der operativen und onkologischen Dermatologie. Bd. 16 Blackwell, Berlin-Wien 192-197, 2000.